<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-29T22:56:05Z</responseDate><request verb="GetRecord" identifier="oai:munzur-rdlopen.rawdatalibrary.net:munzur/3559" metadataPrefix="oai_dc">https://munzur-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:munzur-rdlopen.rawdatalibrary.net:munzur/3559</identifier><datestamp>2026-10-28T15:39:32Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_munzur_1</setSpec><setSpec>col_munzur_2</setSpec><setSpec>com_munzur_8</setSpec><setSpec>col_munzur_154</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Paenidigyamycin g: 1-acetyl-2,4-dimethyl-3-phenethyl-1H-imidazol-3-ium</dc:title><dc:creator>Tetevi, Gilbert Mawuli</dc:creator><dc:creator>Kwain, Samuel</dc:creator><dc:creator>Mensah, Thomas</dc:creator><dc:creator>Camas, Anil Sazak</dc:creator><dc:creator>Camas, Mustafa</dc:creator><dc:creator>Dofuor, Aboagye Kwarteng</dc:creator><dc:creator>Azerigyik, Faustus Akankperiwen</dc:creator><dc:creator>Oluwabusola, Emmanuel</dc:creator><dc:creator>Deng, Hai</dc:creator><dc:creator>Jaspars, Marcel</dc:creator><dc:creator>Kyeremeh, Kwaku</dc:creator><dc:subject>Alkaloid</dc:subject><dc:subject>Antileishmanials</dc:subject><dc:subject>Antitrypanosomals</dc:subject><dc:subject>Imidazole</dc:subject><dc:subject>Leishmaniasis</dc:subject><dc:subject>Paenibacillus</dc:subject><dc:subject>Trypanosomiasis</dc:subject><dc:description>The Ghanaian Paenibacillus sp. DE2SH (GenBank Accession Number: MH091697) is a prolific producer of potent antiparasitic alkaloids. Further detailed study of the culture broth of this strain produced the compound Paenidigyamycin G (1), which is a derivative of the known antiparasitic compound Paenidigyamycin A (2). Compound (1) was isolated on HPLC at tR ≈ 37.5 min and its structure determined by IR, UV, MS, 1D, and 2D-NMR data. Compound 1 produced weak to moderate antileishmanial and antitrypanosomal activity when tested against Leishmania donovani (Laveran and Mesnil) Ross (D10) and Trypanosoma brucei subsp. brucei strain GUTat 3.1 with IC50 = 115.41 and 28.75 µM, respectively. This result is interesting since the parent compound 2 is known to possess consistent and potent antiparasitic activity. However, 1 displayed a promising selectivity profile towards T. brucei subsp. brucei due to its relatively low toxicity against normal mouse macrophages RAW 264.7 cells (SI = 8.70). Given that compound 1 is also the main metabolite found in the hexane fraction of all extracts produced by Paenibacillus sp. DE2SH when it is co-cultured with other bacteria strains, it must possess some unique biological functions which should make it an excellent candidate for further biological activity screening in other bioassays.</dc:description><dc:publisher>MDPI AG</dc:publisher><dc:date>2019</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/munzur/3559</dc:identifier><dc:identifier>https://doi.org/10.3390/m1094</dc:identifier><dc:identifier>1422-8599</dc:identifier><dc:language>en</dc:language><dc:relation>MolBank</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://munzur-rdlopen.rawdatalibrary.net/tr/items/munzur/3559</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>